comparemela.com
  1. Home
  2. Live Updates
  3. Metastatic Prostate Cancer Treatment - Breaking News

Latest Breaking News On - Metastatic prostate cancer treatment - Page 1 : comparemela.com

Practical Application of PARP Inhibitors in Metastatic CRPC

Expert panelists consider the real-world application of PARP inhibitor data in patients with metastatic castration-resistant prostate cancer.

Key updatesMetastatic prostate cancer treatment

IO Therapy in mCRPC and Clinical Pearls

Before sharing clinical pearls for the treatment of prostate cancer, key opinion leaders reflect on the potential use of immune checkpoint inhibitors in mCRPC.

Key updatesMetastatic prostate cancer treatmentClinical pearls

Metastatic CRPC: Advent of PARP Inhibitors

Comprehensive insight on the evolving role of PARP inhibitors in metastatic castration-resistant prostate cancer and clinical trials in this setting.

Key updatesMetastatic prostate cancer treatmentProstate cancerMetastatic castration resistant prostate cancerCastration resistant prostate cancerParp inhibitionParp inhibitorsNovel therapyCombination therapyDoublet therapyPropel trialPropel studyMagnitude trialMagnitude studyTalapro 2

Overview of the Metastatic Castration-Resistant Prostate Cancer Treatment Paradigm

Expert oncologists briefly review the current treatment paradigm of metastatic castration-resistant prostate cancer (mCRPC).

Key updatesMetastatic prostate cancer treatmentProstate cancerMetastatic castration resistant prostate cancerCastration resistant prostate cancerMechanisms of resistanceSequencing therapyTreatment paradigmTreatment landscape

Educating Patients on Treatment Options in Metastatic HSPC

Expert insight on methods to educate patients on available treatment options in the setting of metastatic hormone-sensitive prostate cancer.

Key updatesMetastatic prostate cancer treatmentTreatment optionsProstate cancerMetastatic hormone sensitive prostate cancerHormone sensitive prostate cancerNovel therapyDoublet therapyTriplet therapyClinical trialsSelecting therapySelecting treatmentPatient education

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.